QVT Associates GP LLC 4
4 · Myovant Sciences Ltd. · Filed Jun 6, 2019
Insider Transaction Report
Form 4
QVT Associates GP LLC
Director10% OwnerOther
Transactions
- Purchase
Common Shares, $0.000017727 par value per share
2019-06-04$8.25/sh+2,424,242$19,999,997→ 40,765,599 total(indirect: see fn)
Footnotes (1)
- [F1]QVT Financial LP, its general partner, QVT Financial GP LLC, QVT Financial Investment Cayman Ltd. and QVT Associates GP LLC, the general partner of certain funds managed by QVT Financial LP (collectively, "QVT"), may be deemed to have beneficial ownership over the 40,765,599 Common Shares held by Roivant Sciences Ltd. ("Roivant") because, as shareholders of Roivant, QVT may be deemed to have dispositive power and, therefore, beneficial ownership, over the Common Shares held by Roivant by virtue of governance arrangements in Roivant's bye-laws. The filing of this statement shall not be deemed an admission that QVT is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. QVT expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.